Viking Therapeutics, Inc. (VKTX): Price and Financial Metrics

Viking Therapeutics, Inc. (VKTX)

Today's Latest Price: $6.73 USD

0.09 (1.36%)

Updated Feb 14 12:00am

Add VKTX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

VKTX Daily Price Range
VKTX 52-Week Price Range

VKTX Stock Price Chart More Charts

VKTX Price/Volume Stats

Current price $6.73 52-week high $11.03
Prev. close $6.64 52-week low $6.10
Day low $6.52 Volume 1,063,600
Day high $6.81 Avg. volume 997,129
50-day MA $7.33 Dividend yield N/A
200-day MA $7.47 Market Cap 486.34M

Viking Therapeutics, Inc. (VKTX) Company Bio

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead clinical program, VK5211, is an orally available, non-steroidal selective androgen receptor modulator in Phase II development for the treatment of patients recovering from non-elective hip fracture surgery; in Phase I clinical trials for improving lean body mass; and in pre-clinical trial for improving bone mineral density, bone mineral content, bone strength, and other measures. The company is also developing VK2809, an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta, which is in a Phase II clinical trial for the treatment of patients with hypercholesterolemia and fatty liver disease; and in a Phase I clinical trial to treat patients who suffer from glycogen storage disease type Ia. In addition, it is developing VK0214 for X-linked adrenoleukodystrophy, which is in pre-clinical stage. Viking Therapeutics, Inc. was founded in 2012 and is based in San Diego, California.

VKTX Latest News Stream

Event/TimeNews Detail
Loading, please wait...

VKTX Latest Social Stream

Loading social stream, please wait...

View Full VKTX Social Stream

VKTX Price Returns

1-mo -6.27%
3-mo -8.19%
6-mo -5.48%
1-year -25.80%
3-year 334.19%
5-year N/A
YTD -16.08%
2019 4.84%
2018 88.42%
2017 241.18%
2016 -65.10%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5898 seconds.